Ezrin, a membrane-cytoskeletal linking protein, is involved in the process of invasion of endometrial cancer cells

Cancer Letters

Volumn 147, Issue 1-2, 1999, Pages 31-38

  Ohtani, Kaori ^a,b   Sakamoto, Hideki ^b   Rutherford, Thomas ^a   Chen, Zhaocong ^a   Satoh, Kazuo ^b   Naftolin, Frederick ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endometrial cancer cells; Ezrin; Membrane cytoskeleton; Tumor invasion

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; EZRIN; MATRIGEL; MEMBRANE PROTEIN; PHOSPHOROTHIOIC ACID DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL CLONE; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; DRUG SYNTHESIS; ENDOMETRIUM CANCER; HUMAN; HUMAN CELL; METASTASIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

ADENOCARCINOMA; ALPHA CATENIN; BLOTTING, NORTHERN; CELL DIVISION; CELL MOVEMENT; COLLAGEN; CYTOSKELETAL PROTEINS; DRUG COMBINATIONS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LAMININ; MEMBRANE PROTEINS; MEMBRANES, ARTIFICIAL; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHOPROTEINS; PROTEOGLYCANS; RNA, MESSENGER; SPECTRIN; TUMOR CELLS, CULTURED;

EID: 0032708603     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00272-4     Document Type: Article

References (17)

1. Vaheri A., Carpen O., Heiska L., Helander T.S., Jaaskelainen J., Majander-Nordenswan P., Saino M., Timonen T., Turunen O. The ezrin protein family: membrane-cytoskeleton interactions and disease associations. Curr. Opin. Cell Biol. 9:1997;659-666.
2. McClatchery A.I., Saotome I., Mercer K., Crowley D., Gusella J.F., Bronson R.T., Jacks T. Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev. 12:1998;1121-1133.
3. Ichikawa T., Masumoto J., Kaneko M., Saida T., Sagara J., Taniguchi S. Moesin and CD44 expression in cutaneous melanocytic tumors. Br. J. Dermatol. 138:1998;763-768.
4. Bohling T., Turunen O., Jaaskelainen J., Carpen O., Sainio M., Wahlstrom T., Vaheri A., Haltia M. Ezrin expression in stromal cells of capillary hemangioblastoma. An immunohistochemical survey of brain tumors. Am. J. Pathol. 148:1996;367-373.
5. Fazioli F., Wong W.T., Ullrich S.J., Sakaguchi K., Appella E., Di Fiore P.P. The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation. Oncogene. 8:1993;1335-1345.
6. Kaul S.C., Mitsui Y., Komatsu Y., Reddel R.R., Wadhwa R. A highly expressed 81-kDa protein in immortalized mouse fibroblasts: its proliferative function and identity with ezrin. Oncogene. 13:1996;1231-1237.
7. Bretscher A. Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor. J. Cell Biol. 108:1989;921-931.
8. Nishida M., Kasahara K., Kaneko M., Iwasaki H. Establishment of a new human endometrial adenocarcinoma cell line. Ishikawa cells, containing estrogen and progesterone receptors. Acta Obstet. Gynaecol. Jpn. 37:1985;1103-1111.
9. Sakamoto S., Deng X., Shirakawa T., Ige S., Ohtani K., Saitoh A., Takami M., Takami T., Satoh K. Establishment of metastatic sub-clone from estrogen independent Ishikawa cells and its characterization in vitro and in vivo. Acta Obstet. Gynaecol. Jpn. 47:1995;249-256.
10. Gould K.L., Bretscher A., Esch F.S., Hunter T. cDNA cloning and sequencing of the protein-tyrosine kinase substrate, ezrin, reveals homology to band 4.1. EMBO J. 8:1989;4133-4142.
11. Weiss L. Biophysical aspects of the metastatic cascade. Weiss L. Fundamental Aspects of Metastasis. 1976;51-70 New York, North-Holland Publishing Co.
12. Berryman M., Franck Z., Bretscher A. Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J. Cell Sci. 105:1993;1025-1043.
13. Nicolson G.L. Gene expression, cellular diversification and tumor progression to the metastatic phenotype. Bioessays. 13:1991;337-342.
14. Cunningham C.C., Gorlin J.B., Kwiatkowski D.J., Hartwig J.H., Janmey P.A., Byers H.R., Stossel T.P. Actin-binding protein requirement for cortical stability and efficient locomotion. Science. 255:1992;325-327.
15. Kincade P.W., Zheng Z., Katoh S., Hanson L. The importance of cellular environment to function of the CD44 matrix receptor. Curr. Opin. Cell Biol. 9:1997;635-642.
16. Kleinman H.K., McGaruey M.L., Liotta L.A., Roberg P.G., Tryggvaen K., Martin G.R. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from EHS sarcoma. Biochemistry. 21:1982;6188-6193.
17. Tsukita S., Yonemura S., Tsukita S. ERM proteins: head-to-tail regulation of actin-plasma membrane interaction. Trends Biochem. Sci. 22:1997;53-58.